@bedger Your comment about cash flow positive is at the nub of the matter. $587,000 revenue last quarter - much higher than next highest quarter - $482,000. If multiplied by four to get a full year's revenue - not bad at more than $2.3m. Market cap to sales ratio of about five to one - better then most medical companies. The problem is the very large losses - mostly to do with making the sales. If each quarter sales could increase without increasing costs - perhaps some hope.
Ann: Investor Presentation, page-36
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
